Search

everythinglearnresearchcommunity

for

Search:↓

Most dermatologists in Western Rajasthan prefer the anti-depressant Doxepin for elderly skin conditions and often refer patients to a psychiatrist.

Skin reactions to antidepressants are common but usually not serious and can be treated.

Finasteride can cause depression, suicidal thoughts, and lasting psychiatric and sexual issues.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Neurosteroids help protect the brain and improve behavior after a stroke in mice.

Progesterone and its byproducts control a specific receptor in the brain independently of progesterone receptors, affecting conditions related to the menstrual cycle.

Increasing TSPO in the brain reduces anxiety and depression.

Many skin patients also have mental health issues, and doctors should treat both together.

Finasteride use changes brain chemicals, causing lasting sexual issues and anxiety/depression.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

Some medications can change hair color, especially chloroquine and cancer treatments.

Neurosteroids in the brain can increase or decrease seizure risk in mice.

Bacopa procumbens extract may help protect the brain in Parkinson's disease.

Effective treatments for trichotillomania include cognitive-behavioral therapy, certain medications, and alternative support tools.

Finasteride given to baby rats reduces dopamine release and increases alcohol consumption in adult males.

Certain drugs can change hair color, either lightening or darkening it.

Ethanol blocks memory formation in rats by enhancing certain brain chemicals.

Topiramate may help improve disruptive behaviors in children with bipolar disorder.

Off-label drug use can be risky but sometimes beneficial when standard treatments fail.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Certain medications, especially Paroxetine, Tamsulosin, and Finasteride, are linked to ejaculatory disorders.

Dutasteride may protect brain cells in early Parkinson's, while progesterone helps neuron recovery.

DHT is needed for long-term depression, while E2 is needed for full long-term potentiation in male rat brains.

Current drug safety systems fail to detect long-term side effects, needing improvements to protect health and trust.

Certain existing drugs, like glycopyrronium and botulinum toxin type A, may help treat excessive sweating.

Finasteride improved symptoms in a psychotic patient, but more research is needed.

Estrogen and androgen signals control synaptic changes in rat brains.